Open Offer9 Jun 2026, 08:52 am
Parmax Pharma: Open Offer for 26% Stake by Acquirers
AI Summary
Fedex Securities Pvt Ltd, acting as the Manager to the Offer, has announced a public offer for Parmax Pharma Limited. The offer aims to acquire up to 23,46,250 equity shares, representing 26.00% of the expanded voting share capital. This open offer is being made by Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with several persons acting in concert (PACs), in compliance with SEBI (SAST) Regulations, 2011. The offer is intended to acquire a substantial number of equity shares, voting rights, and control of the target company.
Key Highlights
- Open offer to acquire 26% of Parmax Pharma's expanded voting capital.
- Offer is for up to 23,46,250 equity shares.
- Acquirers are Dhiren Chandulal Shah and Sunil Chinubhai Shah.
- The move is in compliance with SEBI (SAST) Regulations, 2011.
- Objective is to gain substantial control of the company.
Price Impact
More from PARMAX